After reviewing new FDA data showing long-marketed decongestant products using phenylephrine are useless unless reconfigured with higher dosages, agency advisers Tuesday (Sept. 12) effectively recommended the oral medications, such as Sudafed PE and Vicks Sinex, be removed from the market. The ball is now tossed into the FDA’s hands. If the agency decides to take the drug off store shelves, the Consumer Healthcare Products Association says the effect will fall on consumers who will be faced with buying a main...